XML 52 R37.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Revenue Recognition and Accounts Receivable Segment revenue by major payor (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Disaggregation of Revenue [Abstract] |
Disaggregation of Revenue | The Company's revenues by segment and primary payor source were as follows:
| Year ended December 31, 2021
| U.S. dialysis |  | Other - Ancillary services |  | Consolidated
Patient service revenues: |  |  |  |  |
Medicare and Medicare Advantage | $ | 6,133,235 |  |  | $ |  | $ | 6,133,235 |
Medicaid and Managed Medicaid | 782,430 |  |  |  |  | 782,430 |
Other government | 328,256 |  |  | 463,385 |  |  | 791,641 |
Commercial | 3,397,697 |  |  | 199,024 |  |  | 3,596,721 |
Other revenues: |  |  |  |  |
Medicare and Medicare Advantage |  |  | 326,696 |  |  | 326,696 |
Medicaid and Managed Medicaid |  |  | 1,321 |  |  | 1,321 |
Commercial |  |  | 15,553 |  |  | 15,553 |
Other(1) | 25,345 |  |  | 40,945 |  |  | 66,290 |
Eliminations of intersegment revenues | (90,796) |  |  | (4,294) |  |  | (95,090) |
Total | $ | 10,576,167 |  |  | $ | 1,042,630 |  |  | $ | 11,618,797 |
(1)Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.
| Year ended December 31, 2020
| U.S. dialysis |  | Other - Ancillary services |  | Consolidated
Patient service revenues: |  |  |  |  |
Medicare and Medicare Advantage(1) | $ | 6,169,226 |  |  | $ |  | $ | 6,169,226 |
Medicaid and Managed Medicaid | 744,862 |  |  |  |  | 744,862 |
Other government(1) | 334,714 |  |  | 380,584 |  |  | 715,298 |
Commercial | 3,370,562 |  |  | 170,394 |  |  | 3,540,956 |
Other revenues: |  |  |  |  |
Medicare and Medicare Advantage |  |  | 419,662 |  |  | 419,662 |
Medicaid and Managed Medicaid |  |  | 1,227 |  |  | 1,227 |
Commercial |  |  | 33,246 |  |  | 33,246 |
Other(2) | 40,571 |  |  | 47,585 |  |  | 88,156 |
Eliminations of intersegment revenues | (145,286) |  |  | (16,743) |  |  | (162,029) |
Total | $ | 10,514,649 |  |  | $ | 1,035,955 |  |  | $ | 11,550,604 |
(1)During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December 31, 2020 has also been recast to conform to the current period presentation. (2)Other consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.
| Year ended December 31, 2019
| U.S. dialysis |  | Other - Ancillary services |  | Consolidated
Patient service revenues: |  |  |  |  |
Medicare and Medicare Advantage(1) | $ | 6,246,636 |  |  | $ |  | $ | 6,246,636 |
Medicaid and Managed Medicaid | 669,089 |  |  |  |  | 669,089 |
Other government(1) | 329,071 |  |  | 352,765 |  |  | 681,836 |
Commercial | 3,286,089 |  |  | 144,256 |  |  | 3,430,345 |
Other revenues: |  |  |  |  |
Medicare and Medicare Advantage |  |  | 264,538 |  |  | 264,538 |
Medicaid and Managed Medicaid |  |  | 606 |  |  | 606 |
Commercial |  |  | 130,823 |  |  | 130,823 |
Other(2) | 32,021 |  |  | 78,940 |  |  | 110,961 |
Eliminations of intersegment revenues | (132,325) |  |  | (14,030) |  |  | (146,355) |
Total | $ | 10,430,581 |  |  | $ | 957,898 |  |  | $ | 11,388,479 |
(1)During the first quarter of 2021, the Company realigned the classification of revenue previously disclosed in the "Other government" category to the "Medicare and Medicare Advantage" category for certain government-reimbursed plans which have structure and payment characteristics similar to traditional Medicare Advantage plans. The classification of revenue for these plans for the year ended December 31, 2019 has also been recast to conform to the current period presentation. (2)Other consists of management service fees earned in the respective Company line of business as well as other non-patient revenue from the Company's U.S. ancillary services and international operations.

X
- References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration